| The FinancialContent Network SocialPicks Community | MarketMinute Monitor | MarketMinute Market Updates | MarketMinute Stock News |
|
Unusual 11 Mid-Day Movers 1/23: GERN, FOR, TPX, STEM Higher; TNL, CRBC, UCBH, MSCC Lower |
|
| Jan 23, 2009 05:39 PM UTC |
|
Tracked Blogger
|
Via StreetInsider.com News Articles:
Geron Corporation (Nasdaq: GERN) 52.2% HIGHER; announced today that the U.S. FDA has granted clearance of the company's Investigational New Drug application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury. Click here for the full report. Forestar Group Inc. (NYSE: FOR) 34.9% HIGHER; said it had received an unsolicited letter from Holland M. Ware in which he stated that he is prepared to make a cash tender offer for any and all shares at $15 per share, under certain conditions, including support of the Board of Directors for the tender offer and
Read the rest of original post »
|
|
|
IN THE PRESS |
|
|
|
|
|
|
| About | RSS | Feedback | Contact Us | Terms of Service | Privacy |
© 2009 FinancialContent Services, Inc. |
|
Data powered by FinancialContent. All Rights Reserved. Quotes delayed at least 20 minutes unless otherwise indicated. |
|
None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. |